Sale!

Phospholipase A2 Receptor Antibody PLA2R Quantitative Test

1,080 د.إ

-10%

The Phospholipase A2 Receptor Antibody (PLA2R) Quantitative Test is a specialized diagnostic procedure aimed at detecting the presence and measuring the concentration of antibodies against the PLA2R in the blood. PLA2R antibodies are significant markers for the diagnosis and monitoring of primary membranous nephropathy (PMN), an autoimmune kidney disorder where the immune system attacks the membranes in the kidney, leading to proteinuria and potential kidney failure if left untreated.

This test is crucial for the early detection and management of PMN, as it helps in differentiating primary membranous nephropathy from secondary forms of the disease, guiding treatment decisions and monitoring response to therapy. It involves a blood sample from the patient, which is then analyzed using advanced immunological techniques to quantitatively measure the PLA2R antibodies.

At DNA Labs UAE, the cost of the Phospholipase A2 Receptor Antibody PLA2R Quantitative Test is set at 1080 AED. The facility ensures precise and reliable results, utilizing state-of-the-art technology and adhering to stringent quality control measures. Patients opting for this test at DNA Labs UAE can expect professional service, with results that provide critical insights into their renal health and autoimmune status, facilitating timely and appropriate medical intervention.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PHOSPHOLIPASE A2 RECEPTOR ANTIBODY PLA2R QUANTITATIVE Test

Test Details

The Phospholipase A2 Receptor Antibody (PLA2R) Quantitative Test is a laboratory test used to detect and measure the levels of PLA2R antibodies in the blood. PLA2R is a protein found on the surface of kidney cells, and the presence of PLA2R antibodies is associated with certain kidney diseases, such as primary membranous nephropathy.

During the test, a blood sample is collected from the patient and sent to a laboratory for analysis. The test measures the quantity of PLA2R antibodies in the blood, which can help in diagnosing and monitoring the progression of primary membranous nephropathy. Higher levels of PLA2R antibodies generally indicate a higher likelihood of the disease.

The PLA2R antibody test is considered a specific and sensitive marker for primary membranous nephropathy and is often used in conjunction with other clinical and laboratory tests to aid in diagnosis and treatment decisions. It can help differentiate primary membranous nephropathy from secondary causes and guide the management of the disease.

It is important to note that the PLA2R antibody test is not used for screening purposes and is typically ordered by a healthcare provider when there is a suspicion of primary membranous nephropathy based on symptoms, such as proteinuria (protein in the urine) and abnormal kidney function tests. The test results, along with other clinical information, can help guide treatment decisions and monitor the response to therapy.

Test Name

PHOSPHOLIPASE A2 RECEPTOR ANTIBODY PLA2R QUANTITATIVE Test

Components

  • Price: 1080.0 AED

Sample Condition

3 mL (1 mL min.) serum from 1 SST tube. Ship refrigerated or frozen.

Report Delivery

Sample: Tue / Fri by 11 am

Report: Same Day

Method

Enzyme Immunoassay

Test type

Kidney disease

Doctor

Nephrologist

Test Department

IMMUNOASSAY

Pre Test Information

No special preparation required

Test Name PHOSPHOLIPASE A2 RECEPTOR ANTIBODY PLA2R QUANTITATIVE Test
Components
Price 1080.0 AED
Sample Condition 3 mL (1 mL min.) serum from 1 SST tube. Ship refrigerated or frozen.
Report Delivery Sample Tue / Fri by 11 am; Report Same Day
Method Enzyme Immunoassay
Test type Kidney disease
Doctor Nephrologist
Test Department: IMMUNOASSAY
Pre Test Information No special preparation required
Test Details

The Phospholipase A2 Receptor Antibody (PLA2R) Quantitative Test is a laboratory test used to detect and measure the levels of PLA2R antibodies in the blood. PLA2R is a protein found on the surface of kidney cells, and the presence of PLA2R antibodies is associated with certain kidney diseases, such as primary membranous nephropathy.

During the test, a blood sample is collected from the patient and sent to a laboratory for analysis. The test measures the quantity of PLA2R antibodies in the blood, which can help in diagnosing and monitoring the progression of primary membranous nephropathy. Higher levels of PLA2R antibodies generally indicate a higher likelihood of the disease.

The PLA2R antibody test is considered a specific and sensitive marker for primary membranous nephropathy and is often used in conjunction with other clinical and laboratory tests to aid in diagnosis and treatment decisions. It can help differentiate primary membranous nephropathy from secondary causes and guide the management of the disease.

It is important to note that the PLA2R antibody test is not used for screening purposes and is typically ordered by a healthcare provider when there is a suspicion of primary membranous nephropathy based on symptoms, such as proteinuria (protein in the urine) and abnormal kidney function tests. The test results, along with other clinical information, can help guide treatment decisions and monitor the response to therapy.